These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5087202)

  • 1. [Circulating serum proteins following radiotherapy in patients with Hodgkin's disease].
    Adamczyk B; Glińska H; Pawlicki M
    Nowotwory; 1972; 22(3):179-88. PubMed ID: 5087202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoelectrophoretic studies of serum proteins in patients with Hodgkin's disease and acute myeloid leukemia].
    Singer Z; Salwa J; Harlozińska A
    Pol Tyg Lek; 1971 Nov; 26(48):1859-62. PubMed ID: 5290167
    [No Abstract]   [Full Text] [Related]  

  • 3. Discriminant analysis of Hodgkin's disease and non-Hodgkin's lymphomas by age and serum proteins.
    Merucci P; Taggi F; Marolla A; Abbolito MR; Vitelli G; Marolla P; Meliffi L; Chiarotti F; Ippolito FM; Ameglio F
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1243-7. PubMed ID: 6567527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoglobulins in Hodgkin's disease.
    Goldman JM; Hobbs JR
    Immunology; 1967 Oct; 13(4):421-31. PubMed ID: 4168096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of splenectomy on the haematological response to radiotherapy in Hodgkin's disease.
    Begent RH; Wiltshaw E
    Br J Haematol; 1974 Jun; 27(2):331-6. PubMed ID: 4843676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peripheral blood indices in various therapeutic methods used in Hodgkin's disease].
    Kholin VV; Korytova LI; Kovryzhkina TA
    Med Radiol (Mosk); 1991; 36(2):22-6. PubMed ID: 1996067
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation therapy for Hodgkin's disease followed by hypothyroidism and then Graves' hyperthyroidism.
    Constine LS; McDougall IR
    Clin Nucl Med; 1982 Feb; 7(2):69-70. PubMed ID: 7060300
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematologic and immunologic status in Hodgkin's disease 5 years after radical radiotherapy.
    Kun LE; Johnson RE
    Cancer; 1975 Nov; 36(5):1912-6. PubMed ID: 1192376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma following radiotherapy for Hodgkin's disease.
    Karp SJ; Bennett MH
    Clin Radiol; 1986 Sep; 37(5):479-81. PubMed ID: 3757420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonspecific mesenchymal reactions and parenchymal damages in the liver of patients with Hodgkin's disease].
    Oehlert W; Musshoff K; Wunsch B; Willmann H; Beck K
    Klin Wochenschr; 1970 Jan; 48(2):126-8. PubMed ID: 5521215
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematologic recovery and deterioration after "successful" radiotherapy for Hodgkin's disease.
    Johnson RE; Kun LE; Belladonna JA; Johnson SK; Brereton HD; Cohen GA
    Ann Intern Med; 1974 Feb; 80(2):213-6. PubMed ID: 4811794
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of serum copper levels in adult patients with Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Thomas FB; Fuller LM; Gamble JF; Shullenberger CC
    Cancer; 1973 Jun; 31(6):1337-45. PubMed ID: 4709950
    [No Abstract]   [Full Text] [Related]  

  • 13. [Program of the combined treatment of Hodgkin's disease. I. Evaluation of the early results of radical radiotherapy by the mantle field technic in patients with Hodgkin's disease in clinical stages I-III].
    Meder J; Fijuth J
    Nowotwory; 1985; 35(3):262-71. PubMed ID: 4088902
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood eosinophilia in Hodgkin's disease and radiation therapy (author's transl)].
    Chabasse D; Oriot M; Larra F
    Sem Hop; 1981 Feb 18-25; 57(7-8):373-8. PubMed ID: 6261373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utilization of "anti-serum specific" immune serums for the study of abnormal circulating proteins (in acute leukemia, Hodgkin's disease and disseminated lupus erythematosus)].
    CAETANO JA; da COSTA S; SOARES AD; da SILVA J
    Gaz Med Port; 1960; 13():575-82. PubMed ID: 13689743
    [No Abstract]   [Full Text] [Related]  

  • 16. The long-term consequences of therapy for Hodgkin's disease are still evolving.
    Gustavsson A
    Acta Oncol; 1997; 36(1):1-2. PubMed ID: 9090956
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum proteins in Hodgkin's disease and malignant lymphoma.
    ARENDS T; COONRAD EV; RUNDLES RW
    Am J Med; 1954 Jun; 16(6):833-41. PubMed ID: 13158372
    [No Abstract]   [Full Text] [Related]  

  • 18. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
    van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
    J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphomas following radiation therapy alone for Hodgkin's disease.
    Trenkner DA; Brownell M; Wasserman TH
    Radiother Oncol; 1986 Jul; 6(3):199-206. PubMed ID: 3749524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in serum proteins and protein-bound hexose in Hodgkin's disease.
    GOULIAN M; FAHEY JL
    J Lab Clin Med; 1961 Mar; 57():408-19. PubMed ID: 13707515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.